OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
24
Results
Show all
Save search
Copy query
Show results for
Unknown
(24)
Publication Date
Release Date
2025
(5)
2024
(5)
2023
(5)
2020
(2)
2019
(2)
2022
(1)
2016
(1)
2015
(1)
2012
(1)
1998
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Large-scale identification of virulence genes from Streptococcus pneumoniae.
Not available
S-EPMC108710
|
biostudies-literature
Cite
Effectiveness of an Enhanced Community Doula Intervention in a Safety Net Setting: A Randomized Controlled Trial.
Not available
S-EPMC10507922
|
biostudies-literature
Cite
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Not available
S-EPMC4304379
|
biostudies-literature
Cite
The Feasibility and Safety of Obtaining Research Kidney Biopsy Cores in Patients with Diabetes: An Interim Analysis of the TRIDENT Study.
Not available
S-EPMC7341767
|
biostudies-literature
Cite
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice.
Not available
S-EPMC9765452
|
biostudies-literature
Cite
Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease.
Not available
S-EPMC9974571
|
biostudies-literature
Cite
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Not available
S-EPMC5052459
|
biostudies-literature
Cite
Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes.
Not available
S-EPMC10103277
|
biostudies-literature
Cite
Unbiased self supervised learning of kidney histology reveals phenotypic and prognostic insights.
Not available
S-EPMC12508135
|
biostudies-literature
Cite
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics.
Not available
S-EPMC12315800
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets